ClinicalTrials.gg
Not yet recruitingNCT06961032ALLIANCEUpdated May 7, 2025

Developing Recommendations to Support Therapeutic Alliance in Eating Disorders Inpatient Treatment

An observational study in Eating Disorders, sponsored by Norfolk and Suffolk NHS Foundation Trust. Not yet recruiting at 3 sites in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-05-07.

Sponsored by Norfolk and Suffolk NHS Foundation Trust · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Nov 2025, 1 year ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
30
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 28 studies in Feeding and Eating Disorders with a site in United Kingdom — 5 open to participants now, 7 under way, none of them phase 3. Feeding and Eating Disorders · United Kingdom.

Started
2025
with 2 others
Observational
8 of 28
3 open now
Registered
25th of 28
by date
Lead sponsor
1 of 28
Norfolk and Suffolk NHS Foundation Trust

Among the 28 studies in Feeding and Eating Disorders with a site in United Kingdom, this one is one of 3 that started in 2025, is one of 8 observational ones, and was the 25th registered.

Feeding and Eating Disorders

645 studies on the registry are indexed under Feeding and Eating Disorders; 151 are open to participants now.

Browse Feeding and Eating Disorders studies →

Open to participants now

5 of the 28 studies in Feeding and Eating Disorders with a site in United Kingdom are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 99 Feeding and Eating Disorders studies recruiting now, 31 (31%) set no upper age limit and 66 (67%) stop at 75 or younger; 45 take children under 18; 20 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 28 studies in Feeding and Eating Disorders with a site in United Kingdom, or all of them as a file.
02

Study summary

The ALLIANCE study aims to understand and improve treatment relationships between staff and service users in inpatient eating disorder settings. It is NIHR funded and consists of 3 work packages (WP): WP1: Develop Programme Theory using realist literature review to identify how to effectively develop therapeutic alliance in inpatient treatment for Eating Disorders (ED), that maintains safety, whilst leading to improved treatment outcomes. WP1 consists of a literature review, using realist methods. Conducting this review will help us to understand existing evidence relating to treatment relationships in inpatient eating disorder setting. This WP is already underway. WP2: Test, expand and refine the theory via realist interviews with people who have lived experience of inpatient ED treatment and healthcare staff working in inpatient ED settings. Use the Programme Theory to develop actionable practice and policy recommendations to improve treatment outcomes, that can be operationalised (in a future study) into a complex intervention to improve alliance and treatment outcomes for ED. WP3: Codesign an animation (and supporting materials) with people with lived experience, to disseminate and communicate WP2 findings.

Read the detailed description

The ALLIANCE study aims to understand and improve treatment relationships between staff and service users in inpatient eating disorder settings. It is NIHR funded and consists of 3 work packages (WP): WP1: Develop Programme Theory using realist literature review to identify how to effectively develop therapeutic alliance in inpatient treatment for Eating Disorders (ED), that maintains safety, whilst leading to improved treatment outcomes. WP1 consists of a literature review, using realist methods. Conducting this review will help us to understand existing evidence relating to treatment relationships in inpatient eating disorder setting. This WP is already underway. WP2: Test, expand and refine the theory via realist interviews with people who have lived experience of inpatient ED treatment and healthcare staff working in inpatient ED settings. Use the Programme Theory to develop actionable practice and policy recommendations to improve treatment outcomes, that can be operationalised (in a future study) into a complex intervention to improve alliance and treatment outcomes for ED. WP3: Codesign an animation (and supporting materials) with people with lived experience, to disseminate and communicate WP2 findings

Eating disorders (EDs), such as anorexia nervosa, bulimia nervosa or binge eating disorder are serious psychiatric disorders marked by abnormal eating and/or weight-control behaviours. They have the highest mortality rates of any psychiatric disorder in the UK. EDs are devastating to quality of life and expensive to treat - making them 'disabling, deadly and costly'. EDs are also prevalent: it is estimated that 1 in 5 women may have an ED, although males, trans and non-binary individuals are also increasingly affected. Inpatient treatment is reserved for the most unwell and high-risk patients, admissions for EDs are increasing, but rates of recovery remain low and long-term recovery following inpatient treatment is inconsistent. Intensive inpatient treatment is expensive yet drop-out rates and disengagement are extremely high (up to 60%) . Given the prevalence of EDs, their high mortality rates and the lack of successful treatment options for acute patients, understanding why inpatient treatment is often ineffective, and developing novel responses to this, are desperately needed. Due to the risk of serious illness and death, inpatient treatment of EDs prioritises physical safety and weight gain over psychological needs. This is operationalised into policy that dictates statutory frameworks that have a direct bearing on how care is delivered (such as inspections delivered by the Care Quality Commission). This policy is enacted through interactions between front-line staff and service users leading to practices such as monitoring (e.g., all food and drink intake), withholding (e.g., not allowing people to have time alone) and surveillance (e.g., constantly watching people, including in the toilet). Whilst important from a safety perspective, these practices are distressing to both service users and staff and have been found to undermine trust and the development of positive therapeutic relationships. This is critical as poor therapeutic alliance has been found to be related to drop-out from treatment and is a significant predictor of longer-term recovery. The literature on ED in-patient treatment highlights that inpatient practices designed to prioritise physical safety have a negative impact on the development of therapeutic alliance. What is not currently understood is how inpatient treatment undermines the therapeutic alliance (that is, the mechanisms of change underlying the relationship between therapeutic alliance, disengagement from treatment and recovery from the ED) or how this could be improved in clinical practice. It is crucial to improve therapeutic alliance, as this has been associated with engagement in treatment and treatment outcomes. Relationships between healthcare staff and service users are impacted by a wide range of complex systemic factors, such as, policy and management systems, the anxiety of clinical responsibility for managing high levels of risk, and the dissonance caused by delivering practices are counter to personal values of collaborative care. The ALLIANCE project therefore also integrates a systems-based approach to understand what support systems are required to enable staff to effectively establish therapeutic relationships, whilst safely managing high levels of risk. Therapeutic alliance is related to treatment outcomes for EDs and is a significant predictor of disengagement from treatment. Research suggests that inpatient practices, erode service users' trust in, and engagement with, healthcare staff and ultimately undermine factors that are associated with personal recovery, such as identity, confidence, and agency. Additionally, it has been found that inpatient practices, via complex mechanisms (discussed below), can cause staff to participate in behaviour that can further result in the breakdown of therapeutic alliance. What is not currently known is how staff can deliver inpatient treatment, that maintains physical safety but does not do this at the cost of the therapeutic alliance. There is a range of research on experiences of inpatient treatment for EDs which has largely focused on anorexia nervosa and bulimia nervosa (due to the greater likelihood of these diagnosis leading to inpatient care). This research highlights the difficulty of staff and service users working together in inpatient settings which can be oppressive, stressful and (often) ineffective. Healthcare is ideally regarded as a partnership between professionals and their patients, but with regard to EDs, this dynamic has been understood as complex and often fraught. The importance of therapeutic alliance to recovery from ED stresses that honesty, empathy, commitment and a non judgement attitude are the linchpins of therapeutic alliance. As observed by Ramjan et al (2004), 'without a trusting, therapeutic ... relationship, the treatment and recovery of people with anorexia can be unnecessarily impeded and prolonged'. However, achieving trust between patient and treatment provider is often especially challenging. Service user trust has been associated with being listened to, treated as a person/ individual rather than an illness or diagnosis, and perceiving that staff are knowledgeable, competent and well-meaning. Trust is also related to systemic factors (e.g., trust that healthcare organisations, their priorities and protocols, have their best interest in mind). ED service users have emphasised the importance to engagement of feeling that they are actively involved in treatment. Help-seeking behaviours and engagement are also highly influenced by trust in staff members and the service user's perception that they are receiving person-centred care. Despite existing clinical research which suggests that treatment rationales should always be clear for service users, research indicates that they are routinely denied such explanations in ways which impact trusting relationships. As identified by a service user in the Holmes (2021) study "There wasn't often a rationale. It was often just "you're ill" or "you're angry" ... it made me feel untrusted, and like I wasn't worth listening to". This in turn engenders antagonism toward staff and treatment as it fosters the perception that some rules or restrictions are punitive rather than being driven by a safety rationale, which can also result in disengagement from treatment. Graham et al (2020) conducted a meta-ethnography of 37 studies of staff perspectives of working in ED services, which sheds light on why therapeutic alliance breaks down from the staff perspective. This found a primary theme of "caring without curing", which identified that a combination of chronicity of illness, treatment refusal, and systemic challenges confronted staff with the fact that their care and treatment might be unwanted and/or insufficient. The result was a mismatch between the desire to help and the reality of what they were able to offer. Together, these factors resulted in expressions of moral distress as staff experienced a conflict between systemic practices (such as surveillance) that were perceived as a violation of their core values. This moral distress manifested as both self criticism and the development of dehumanising narratives about service users. Staff were found to adopt coping strategies to defend against dissonance such as avoiding, blaming, and battling with service users. Poor treatment outcomes may also arise from systemic frameworks involving rigid systems of monitoring and surveillance, which deny patient autonomy and control, and which are enacted in the relationship between staff and service users, replicating and intensifying some of the structures of ED itself. In terms of current practice, relapse rates remain high, and inpatient stays may result in 'poorer psychosocial outcomes than community-based treatment in the longer term. The experience of inpatient treatment itself, including the relationships with healthcare staff, may actually work against the wider goal of recovery from an ED. Additionally, research has shown that the experience of restrictive inpatient practices, and the subsequent mistrust of services, is likely to persist following discharge from inpatient units, as it can undermine trust in health services in general. This can lead to a lack of engagement with community services following discharge, which may in turn lead to deterioration in the community and subsequent readmission to the inpatient context. Achieving good therapeutic alliance is likely to overcome some of these problems as factors found to be associated with the experience of the therapeutic relationship, such as sense of identity, agency and social connection, are also domains of personal recovery from ED. Additionally, self compassion and self-acceptance have been found to be critical domains of personal recovery from ED that can be fostered by a compassionate, kind and non judgemental therapeutic relationship. We have conducted an initial scoping search that has identified a range of literature that starts to explain the observed relationship between therapeutic alliance and treatment outcomes for ED. However, a systematic understanding of the mechanisms of change underlying this, and how this can be improved in practice, is not currently available to service providers, policymakers and researchers. Additionally, to date, the research has largely lacked a systems-based perspective, to identify how factors such as healthcare policy, local risk management protocols, and clinical supervision structures impact on therapeutic alliance. Lastly, patients and health professionals tend to be studied separately. This arguably reflects a wider 'research-practice' gap in the field of understanding how patient and staff experience, sense-making and behaviour interact to develop of undermine therapeutic alliance and effective inpatient treatment for EDs.

Work Package 1 will develop programme theory using realist methods, and informed by a systems-based approach. Evidence will be collected from peer reviewed research, and used to develop an initial programme theory. Further iterative searches will be conducted, including grey literature and policy documents. Expert stakeholder will also contribute to programme theory development. A systems approach will be used to map personal, service, organisational, local and national level contexts that influence treatment relationships and subsequent outcomes. Review stage 1 output will be the initial programme theory. WP2: The programme theory will be tested, expanded and refined using iterative realist interviews. We will conduct 10 service user, and 10 staff realist interviews across our recruitment pathways (total n = 20). This sample size is considered adequate to ensure enough data is collected to test, expand and refine the programme theory. The literature synthesis will explore the impact of attributes such as gender, ethnicity, neurodiversity and duration of illness. We will recruit in line with testing emerging programme theory relating to these factors. To ensure diversity, there will be targeted recruitment and purposive sampling from the clinical sites and from the charity and third sector contexts. Staff interviews will include staff from across different levels of the system (e.g., nurses, including agency staff as suggested by lived experience collaborators, clinical psychologists, psychiatrists, managers, and the board). Interview topic guides will be developed from the initial programme theory, with input from key stakeholders. Interviewees will be presented with observations identified from our programme theory, and asked if they agree or disagree, as well as to expand on the issue based on their own experiences. These interviews can provide new evidence not already identified in the literature. WP3: We will co-design a video animation with accompanying material to communicate the programme theory and recommendations. The animation will be co-designed with service users and staff interviewed in WP2 and the lived experience collaborators. The animation will bring to life the findings of the realist synthesis, foregrounding the lived experiences of service users and staff by representing scenes where trust and therapeutic alliance is enhanced or undermined in ED in-patient treatment. This will include the key recommendations for practice to improve therapeutic relationships between healthcare staff and service users. To develop the animation, we will recruit service-users and staff (n=8-10, total) for co-design groups. We will conduct two 1.5-2 hour co-design workshops. The workshop will initially present the findings of the realist synthesis, then the recommendations derived from the programme theory. We will explore the needs of both service users and staff in relation to the animation and the accompanying materials. Participants will identify key issues that are and are not working in ED inpatient treatment and how this could be improved in practice. These will then be prioritised (as to what should be included in the animation). After the workshop we will collate the suggestions and share them with participants via email. The second co-design workshop will be organised online via secure video-call. Participants from both in person groups will attend together. The workshop will generate, refine and select ideas from previous workshops for scenes and topics to be included in the animation, as well as for a preliminary storyboard. After the workshop, a storyboard created by designers will be shared with participants via email for feedback. To finalise practice and policy recommendations we will run two feedback groups to present the animation to stakeholders, including healthcare staff and lived experience advisors and collaborators. The research team will use this stakeholder discussion to finalise recommendations. We will also collect stakeholder feedback on the animations in these events through a short questionnaire both on the materials and their use. As the content of the questionnaire is dependent upon the outcome of WP1 \& 2, this will be developed later on in the study

03

Conditions studied

  • Eating Disorders

Keywords

  • eating disorders
  • therapeutic alliance
  • inpatient care
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adults who have a prior diagnosis of ED and who have lived experience of being admitted onto an inpatient ED ward. Participants are identified from community ED teams and advertised through national ED support charities.

Healthcare professional participants who have a professional experience of working on inpatient ED wards will be approached through participating NHS sites and national ED charities.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Clinical population: All service users (18 years and over), with capacity to give , admitted within the previous 5 years to inpatient ED units will be eligible for inclusion in the study Staff: All staff with clinical roles in inpatient ED units.

Exclusion criteria

Exclusion Criteria:

  • No additional exclusion criteria
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
30 participants (estimated)
Patient registry
No

Groups and cohorts

  • Service Users with diagnosis of ED

    Adults 18+ who have received a diagnosis of any ED, and have previously been admitted to an inpatient mental health ward for treatment within the last 5 years.

  • Healthcare Professionals

    Healthcare professionals with experience of working in an inpatient eating disorders unit.

06

What researchers measure

Primary outcomes

  1. Qualitative experiences of inpatient eating disorder treatment

    Qualitative semi-structured interviews with ED service users and healthcare professionals abut their experiences and perceptions of inpatient ED treatment and care.

    Time frame: Within the past 5 years of discharge from inpatient ED services.

07

Study locations

3 sites
  • Leicestershire Partnership NHS Trust
    Leicester, Leicestershire LE3 8RA, United Kingdom
    • Leanne Haynes, MSc · Contactleanne.haynes1@nhs.net · 0116 225 2583
    • Leanne Haynes, MSc · Principal investigator
  • Newmarket House Clinic
    Norwich, Norfolk NR4 6SY, United Kingdom
  • Norfolk and Suffolk NHS Foundation Trust
    Norwich, Norfolk NR6 5BE, United Kingdom
    • Corinna J Hackmann, PhD, ClinPsyD · Contactcorinna.hackmann@nsft.nhs.uk · 01603 421397
    • Corinna J Hackmann, PhD ClinPsyD · Principal investigator
08

References and documents

Individual participant data

Plan to share: No — Anonymised qualitative data about service experiences and experiences of individual practitioners will not be shared publicly by agreement with ethics board due to sensitive nature of responses.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for May 2025; primary completion for Nov 2025, 6 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 29, 2025
First posted
May 7, 2025
StartEst.
May 2025
Primary completionEst.
Nov 2025
CompletionEst.
Nov 2025
Last update
May 7, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 7, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06961032
Lead sponsor
Norfolk and Suffolk NHS Foundation Trust
Collaborators
Loughborough University, University of East Anglia
Responsible party
Sponsor
First posted
May 7, 2025
Start date
May 2025 (estimated)
Primary completion
Nov 2025 (estimated)
Completion
Nov 2025 (estimated)
Last update
May 7, 2025

Study contacts

Charlotte J Wheeler, MSc
Contact
charlotte.wheeler@nsft.nhs.uk
01603 421397
Lisa M Gruenwald, PhD
Contact
lisa.grunwald@nsft.nhs.uk
01603 421397
Corinna J Hackmann, PhD, ClinPsyD
principal investigator · Norfolk and Suffolk NHS Foundation Trust
Susan Holmes, PhD
principal investigator · University of East Anglia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion